BACKGROUND: Estrogen is known to have important effects on both reproductive and non-reproductive tissues. Moreover, there is increasing interest in developing compounds that may have selective effects on bone versus reproductive tissues. METHODS: Since mouse models are often used in these studies, we administrated increasing doses of estradiol (E2) (0 to 500 microg/kg/day) by slow release pellets to ovariectomized 6-month-old C57BL/6 mice and assessed skeletal and uterine responses following 2 months of treatment. RESULTS: The mice lost bone at multiple sites following ovariectomy (OVX); however, while the lowest E2 dose of 5 microg/kg/day completely prevented loss of cancellous bone (at the lumbar spine and tibial metaphysis), it had no stimulatory effects on the uterus. Higher doses of E2 resulted in further increases in bone mineral density, with eventual stimulation of the uterus at a dose of 40 microg/kg/day. By contrast, when 3-month-old C57BL/6 mice were administered the same doses of E2 and studied after 1 month, the 5 microg/kg/day dose resulted in uterine hypertropy, but was not able to prevent loss of cancellous bone. CONCLUSIONS: Thus these results (i) provide data on the dose-response for the effects of E2 on mouse bone and (ii) indicate that the relative effects of E2 on bone versus the uterus are highly dependent on the particular experimental conditions used. This issue needs to be considered in evaluating agents with potential 'selective' effects on bone versus reproductive tissues.
BACKGROUND: Estrogen is known to have important effects on both reproductive and non-reproductive tissues. Moreover, there is increasing interest in developing compounds that may have selective effects on bone versus reproductive tissues. METHODS: Since mouse models are often used in these studies, we administrated increasing doses of estradiol (E2) (0 to 500 microg/kg/day) by slow release pellets to ovariectomized 6-month-old C57BL/6 mice and assessed skeletal and uterine responses following 2 months of treatment. RESULTS: The mice lost bone at multiple sites following ovariectomy (OVX); however, while the lowest E2 dose of 5 microg/kg/day completely prevented loss of cancellous bone (at the lumbar spine and tibial metaphysis), it had no stimulatory effects on the uterus. Higher doses of E2 resulted in further increases in bone mineral density, with eventual stimulation of the uterus at a dose of 40 microg/kg/day. By contrast, when 3-month-old C57BL/6 mice were administered the same doses of E2 and studied after 1 month, the 5 microg/kg/day dose resulted in uterine hypertropy, but was not able to prevent loss of cancellous bone. CONCLUSIONS: Thus these results (i) provide data on the dose-response for the effects of E2 on mouse bone and (ii) indicate that the relative effects of E2 on bone versus the uterus are highly dependent on the particular experimental conditions used. This issue needs to be considered in evaluating agents with potential 'selective' effects on bone versus reproductive tissues.
Authors: Stavros C Manolagas; Robert L Jilka; Stavroula Kousteni; Teresita Bellido; Robert S Weinstein; Charles A O'Brien; Lilian Plotkin; Li Han Journal: J Clin Invest Date: 2006-11 Impact factor: 14.808
Authors: Victor H Urbieta-Caceres; Farhan A Syed; Jing Lin; Xiang-Yang Zhu; Kyra L Jordan; Caitlin C Bell; Michael D Bentley; Amir Lerman; Sundeep Khosla; Lilach O Lerman Journal: Am J Physiol Endocrinol Metab Date: 2012-02-07 Impact factor: 4.310
Authors: Young A Yoo; Jieun Son; Fabiola F Mehta; Francesco J DeMayo; John P Lydon; Sang-Hyuk Chung Journal: Am J Pathol Date: 2013-09-05 Impact factor: 4.307
Authors: Kristen E Govoni; Jon E Wergedal; Robert B Chadwick; Apurva K Srivastava; Subburaman Mohan Journal: Am J Physiol Endocrinol Metab Date: 2008-09-23 Impact factor: 4.310
Authors: Gul Zaman; Leanne K Saxon; Andrew Sunters; Helen Hilton; Peter Underhill; Debbie Williams; Joanna S Price; Lance E Lanyon Journal: Bone Date: 2009-10-24 Impact factor: 4.398